Nova Labs manufactures first aseptically spray dried biologic

Nova Laboratories has welcomed the US FDA’s approval of Raplixa from ProFibrix, a Netherlands-based wholly owned subsidiary of The Medicines Company. Raplixa is manufactured at Nova Laboratories sterile manufacturing facilities in the UK and consists of spray dried thrombin and fibrinogen, which are blended and filled aseptically.

See more at:


Download all our latest product lists, this months Newsletter and news articles from Nova Laboratories.


Career Opportunities

We welcome speculative enquiries and applications from anyone with experience in the pharmaceutical industry, the right attitude and relevant qualifications.

Know More

Contact Us

For all product enquires, please contact our customer services team on 0800 975 48 40 or alternatively you can email us at [email protected]